http://imagesignal.comsec.com.au/asxdata/20100217/pdf/01038122.pdf
The study for the ongoing development of OvPlexTM is aiming to prove a diagnostic accuracy of over 97 per cent for early stage ovarian cancer
Add to My Watchlist
What is My Watchlist?